Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer…
Applied Materials, Inc. (NASDAQ: AMAT) has reported better-than-expected fourth-quarter results, but the company's stock slipped soon after the announcement last…